Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Rachel Greer"'
Autor:
Liqin Du, Maria C Subauste, Christopher DeSevo, Zhenze Zhao, Michael Baker, Robert Borkowski, Jeoffrey J Schageman, Rachel Greer, Chin-Rang Yang, Milind Suraokar, Ignacio I Wistuba, Adi F Gazdar, John D Minna, Alexander Pertsemlidis
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e39167 (2012)
NSCLC (non-small cell lung cancer) often exhibits resistance to paclitaxel treatment. Identifying the elements regulating paclitaxel response will advance efforts to overcome such resistance in NSCLC therapy. Using in vitro approaches, we demonstrate
Externí odkaz:
https://doaj.org/article/b9fc3aeea24e43c1af41137baddf1542
Autor:
Ebel Berghuis, Derk Loorbach, Anne van Vulpen, Martijn Verkuijl, Claudia van Orden, Rachel Greer
Publikováno v:
International Review of Applied Economics. :1-17
Autor:
Rolf A. Brekken, John D. Minna, Noelle Williams, Haizhou Sun, Nabeel Bardeesy, Puja Gupta, Jason E. Toombs, Juliet G. Carbon, Rachel Greer, Christina L. Roland, Sean P. Dineen
Supplementary Figures 1-2, Tables 1-2 from Smac Mimetic Increases Chemotherapy Response and Improves Survival in Mice with Pancreatic Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::385ab78fcef9c05f2ee2d1e591e9593e
https://doi.org/10.1158/0008-5472.22387332.v1
https://doi.org/10.1158/0008-5472.22387332.v1
Publikováno v:
Circular Economy and Sustainability.
Because of the need to limit extraction of raw materials and reduce amounts and impacts of waste, countries and businesses are challenged to transition to a circular economy: an economic system in which the materials are reduced, reused, or recycled,
Publikováno v:
Journal of Cleaner Production, 303:126831. Elsevier Ltd.
The European Union has vowed to transition from a linear to a circular economy (CE). Many innovations, new business models, and policies have begun to emerge to support the push for further institutionalizing CE practices. A large portion of these at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af1d675f007a0a479241cdace4a363fc
https://pure.eur.nl/en/publications/6cf09aa2-5d6e-4839-96ea-30c56676380f
https://pure.eur.nl/en/publications/6cf09aa2-5d6e-4839-96ea-30c56676380f
Publikováno v:
Journal of Cleaner Production, 267:121906. Elsevier Ltd.
Alternative ways to provide services based on circular economy principles are facing the problem of diffusing beyond local experimentations in niches to become mainstream. This is the entry point for our case study examining niche experimentation in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0a606b58cd512eb4f149de716f189cc
https://pure.eur.nl/en/publications/7cfd7896-5603-4c0e-8584-9e0488e650b1
https://pure.eur.nl/en/publications/7cfd7896-5603-4c0e-8584-9e0488e650b1
Publikováno v:
Archives of Disease in Childhood. 105:e2.2-e3
BackgroundInternational experts recommended pazopanib to treat a 9 year old boy with a recurrent desmoid tumour. The tumour had progressed, leading to blockage of the airway and dysphagia. The child had previously received three lines of intravenous
Autor:
Adi F. Gazdar, Michael Peyton, Lai Wang, Rolf A. Brekken, Yang Xie, Luc Girard, John D. Minna, Patrick G. Harran, Jill E. Larsen, Rachel Greer, Xiaodong Wang
Publikováno v:
Cancer Research. 71:7640-7648
Inhibitors of apoptosis proteins (IAP) are key regulators of apoptosis and are inhibited by the second mitocondrial activator of caspases (SMAC). Previously, a small subset of TNF-α–expressing non–small cell lung cancers (NSCLC) was found to be
Autor:
Eileen Loucaides, Lies Pottel, Michelle Lycke, Mahesh K. B. Parmar, Jens Samol, Elizabeth Hodgkinson, Donna Kimber, Julie Mason, Susanna Daniels, Rachel Greer, Stephen Kelly, Philip J. Johnson, Sally Harvey, Philip R. Debruyne
Publikováno v:
Clinical trials (London, England). 12(3)
Background Clarity and accuracy of the pharmacy aspects of cancer clinical trial protocols is essential. Inconsistencies and ambiguities in such protocols have the potential to delay research and jeopardise both patient safety and collection of credi
Autor:
Rachel Greer, Sally Harvey
Publikováno v:
Archives of Disease in Childhood. 101:e2.67-e2
AimClarity and accuracy of the pharmacy aspects of cancer clinical trial protocols is essential. Inconsistencies and ambiguities in protocols have the potential to delay research and jeopardise both patient safety and the collection of credible data.